News
Synthego, a Bay Area biotech startup that won hundreds of millions of dollars in funding for its gene editing products and research, filed for bankruptcy earlier this month. Synthego CEO Craig ...
(KRON) — The future of one biotech company on the Peninsula is drastically changing. Unity Biotechnology is laying off its entire workforce, the company announced Monday in a press release.
Unity Biotechnology, a Bay Area company that once won high-profile backers and a $700 million valuation for its research into aging, is now laying off every one of its remaining employees.
Rather, with so much uncertainty, investors are prizing biotech companies that base their intellectual property and manufacturing in the U.S., which up until now often meant higher taxes.
But today, Kendall has been reborn — as the glittering, glassy heart of America’s biotech industry. For many companies, Kendall Square’s status as a global center of biotechnology firms and ...
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech ...
Earlier this week, the congressionally-mandated National Security Commission on Emerging Biotechnology released its major report, titled “Charting the Future of Biotechnology.” The bipartisan ...
The comprehensive report from the bipartisan National Security Commission on Emerging Biotechnology (NSCEB) delivers a “sobering, even frightening,” conclusion: that China is quickly ascending to ...
The AI biotech is also looking to expand its team as it grows. "This funding will further turbocharge the development of our next-generation AI drug design engine, help us advance our own programs ...
In this article, we will be taking a look at the 7 most profitable biotech stocks to buy right now. With improved market conditions, innovative breakthroughs, and more investor interest ...
Dr Liz Fletcher, director of operations and business engagement at the Industrial Biotechnology Innovation Centre (IBioIC) (Picture: Fraser Cameron) This is where the bioeconomy comes into play ...
Biotech stocks offer investors a great way to get in on innovation and growth. These three players may be ripe for a rebound thanks to their solid pipelines. Investors looking for growth in recent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results